Yeah that's a no from me.
Yeah that's a no from me.
I respectfully disagree. I think the last President/Administration did in fact facilitate the COVID-19 vaccines by ensuring those drug companies (Pfizer, Moderna, Johnson & Johnson) had all the resources they needed. I'm sure they went to the head of the line anytime they needed the FDA's attention/approval. How else would those drugs get Emergency Use Authorization inside of a year. They just couldn't interfere with the actual approval process.The last "president" couldn't for COVID-19, so neither can the DoD for hearing loss.
The military can and has sponsored its own experimental drug trials on soldiers in the recent past, and they've done so outside of the jurisdiction of the FDA.
You can sign me up as well @Hazel. I was already planning to write a letter to the CEO of Astellas the Netherlands with recommendations from my ENT, psychologist & psychiatrist for compassionate use but an international coordinated effort sounds way more ambitious.Hi @Bambam0, @AfroSnowman, @Tezcatlipoca, @Zugzug, @Diesel, @FGG!
I just want to add, on behalf of Tinnitus Hub, that we are more than willing to facilitate such an effort. I agree such initiatives should be well coordinated — though of course anyone is free to lobby on their own behalf, but doing this as a community will be much more impactful! Grassroots activism has always been part of who we are and it's a major part of why we run this community. If the Phase 2 90-Day readout is positive, I feel like a working group should be formed.
Oh no - it's gotta travel up-hill after 5 kHz.Here is a schematic. Not sure if it is exactly to scale but shows an approximation of what you are asking anyway:
View attachment 43895
All the other arrows show flow, movement, and/or direction. Pointers are just plain black lines.And through the eardrum. I see what you mean but I put it down to a badly designed diagram. I think it means that the drug starts 'here' (outside the round window).
... [edit] or it doesn't matter where the drug comes from. Once it's in the middle ear, the vibration does its thing.
So you can inject your drug through the eardrum OR via catheter through the eustachian tube. Once in the middle ear it permeates through the round window and down through the cochlea with help from the low frequency vibration.All the other arrows show flow, movement, and/or direction. Pointers are just plain black lines.
How precise is this? Would a small hole in the eardrum interfere with a "closed acoustic system"? If that's the case, you'd almost have to go through the Eustachian tube or a well engineered work around (very slow release gel, wait for hole to heal).So you can inject your drug through the eardrum OR via catheter through the eustachian tube. Once in the middle ear it permeates through the round window and down through the cochlea with help from the low frequency vibration.
I'd be more worried about whether the stresses put on the eardrum would turn the little hole into a big hole. In the experiment they opened up the middle ear. I have no idea how that worked with the 'closed acoustic system'. I think we can assume that there's a way to go on this one.Would a small hole in the eardrum interfere with a "closed acoustic system"?
I think the drug goes up through the eustachian tube and the low frequency sounds are played through the ear drum.And through the eardrum. I see what you mean but I put it down to a badly designed diagram. I think it means that the drug starts 'here' (outside the round window).
... [edit] or it doesn't matter where the drug comes from. Once it's in the middle ear, the vibration does its thing.
It seems it would have to be Eustachian tube delivered as everyone is pointing out. Would suck awake, but sedated with a small gauge red rubber Cath, probably not too bad at all (I think the surgical approach in your link was probably just due to size of rodent model and visualization ease).I'd be more worried about whether the stresses put on the eardrum would turn the little hole into a big hole. In the experiment they opened up the middle ear. I have no idea how that worked with the 'closed acoustic system'. I think we can assume that there's a way to go on this one.
Same here!I hope it will reach at least partially to my loss (30 dB) of hearing and tinnitus at 3 kHz.
I doubt it, given the size of a typical intratympanic needle.Would a small hole in the eardrum interfere with a "closed acoustic system"?
Intratympanic is completely harmless. I received 8 of them in my right ear (every 3 days in a row) without any consequences. It is inconvenient but without consequences.I doubt it, given the size of a typical intratympanic needle.
This was more of an oscillation dynamics thought, not a safety one. Intuitively, it shouldn't make much difference, but they must have chosen the alternate route for some related reason.I doubt it, given the size of a typical intratympanic needle.
Which hospital does your ENT work at? I've recently been referred to an ENT at the Erasmus MC for a separate issue with my eardrum, but I'm going to ask him about tinnitus and (possible) future treatments as well.I was already planning to write a letter to the CEO of Astellas the Netherlands with recommendations from my ENT, psychologist & psychiatrist for compassionate use but an international coordinated effort sounds way more ambitious.
If you may find one, please let me know since I'm also from the Netherlands. I've been trying as well but they all seem so clueless.Which hospital does your ENT work at? I've recently been referred to an ENT at the Erasmus MC for a separate issue with my eardrum, but I'm going to ask him about tinnitus and (possible) future treatments as well.
Unfortunately, all the ENTs I've spoken to so far weren't really willing to administer anything outside of their scope of experience.
As such, I'm passively looking for an ENT who might be willing to administer treatments such as FX-322.
My understanding is they surgically opened up the middle ear cavity and placed the drug directly onto the round window.This was more of an oscillation dynamics thought, not a safety one. Intuitively, it shouldn't make much difference, but they must have chosen the alternate route for some related reason.
I see this has been responded to as normal activity but are the frequency (no pun) of his sales usually this much? I would have thought that if you were privy to to good information and you were able to stop or change sale of shares then you would.Maybe you talked about this already and this is a little old, but is this something normal?
View attachment 43822
Totally normal. 10b5-1 plans are decided 6-12 months in advance.I see this has been responded to as normal activity but are the frequency (no pun) of his sales usually this much? I would have thought that if you were privy to to good information and you were able to stop or change sale of shares then you would.
I like to invest but I never invest in companies in which there is insider selling.
This will be why you will need to go and see specialists working at a FX-322 affiliated practice or go and see an otologist first, should the treatment end up being successful.Which hospital does your ENT work at? I've recently been referred to an ENT at the Erasmus MC for a separate issue with my eardrum, but I'm going to ask him about tinnitus and (possible) future treatments as well.
Unfortunately, all the ENTs I've spoken to so far weren't really willing to administer anything outside of their scope of experience.
As such, I'm passively looking for an ENT who might be willing to administer treatments such as FX-322.
The direction of drug travel should not matter much at the molecular scale that defines the interior of the cochlea. At the spatial scale relevant to molecules inside bodies, diffusion via osmotic gradients play a major role in molecular motion. Also, considering that the cochlea is fluid-filled, it would seem that the delivery medium would simply need to be sufficiently soluble in the cochlear fluid to pervade the whole organ. I really suspect that facilitating thorough diffusion through the cochlea would be a pretty elementary task once researchers turn their attention to it.Oh no - it's gotta travel up-hill after 5 kHz.
As far as I know, they have only done rat toxicology studies so far. That would put the product at the pre-clinical testing phase.For better delivery of FX-322 to the cochlea, there is a device called Otomagnetics.
Does anyone know if it is available?
Thanks for the tireless task of repeating this every two pagesTotally normal. 10b5-1 plans are decided 6-12 months in advance.
I imagine early on we will have a list being shared on Tinnitus Talk of specialists that are giving FX-322 in different countries. Better get on their waiting list early or it will be a long noisy wait.This will be why you will need to go and see specialists working at a FX-322 affiliated practice or go and see an otologist first, should the treatment end up being successful.
My ENT works at the Bronovo hospital in The Hague. My ENT wasn't actually aware of FX-322 when I asked her about it at my first appointment, but she was open-minded enough to do some digging on this treatment. At the second visit, the ENT said she was willing to write a recommendation for compassionate use if the results point to tinnitus alleviation, but she also added that she didn't expect the treatment to become mainstream at general hospitals for years to come, and that it would be more realistic to expect that we receive treatment at clinics or hospitals that are closely aligned with Astellas/Frequency Therapeutics in the short term.Which hospital does your ENT work at? I've recently been referred to an ENT at the Erasmus MC for a separate issue with my eardrum, but I'm going to ask him about tinnitus and (possible) future treatments as well.
Unfortunately, all the ENTs I've spoken to so far weren't really willing to administer anything outside of their scope of experience.
As such, I'm passively looking for an ENT who might be willing to administer treatments such as FX-322.
It's highly likely that Frequency Therapeutics will provide a "search map" on their website for health care providers / clinics offering FX-322 injections. If we learn that multiple injections of this first generation of FX-322 do indeed provide an additional benefit, it would mean that doctors providing the drug would need to have some type of training to understand the dosage amount / schedule needed per patient, and the proper protocols to assess the patient's individual hearing performance.I imagine early on we will have a list being shared on Tinnitus Talk of specialists that are giving FX-322 in different countries. Better get on their waiting list early or it will be a long noisy wait.